New 4D Scale Enhances Migraine Severity and Treatment Insights
- MigraineMind
- Dec 19, 2025
- 1 min read
Research Summary
A new study published in Cephalalgia introduces the four dimensions 4D migraine scale, a novel tool designed to comprehensively evaluate migraine severity and treatment efficacy. Researchers created this composite scale by integrating monthly migraine days (MMDs), monthly acute medications (MAMs), pain intensity, and the Migraine Disability Assessment (MIDAS) Score. Through Conjoint Analysis with 197 migraine patients and 118 headache experts, they determined the relative importance of each parameter. MMDs emerged as the most critical factor, while pain intensity was deemed least important. The 4D score ranges from 0 to 100, showing strong concurrent validity with the Head Impact Test HIT-6, making it a promising tool for assessing migraine burden and treatment success.
Study Details
👥 Research Team: Pasqualetti P et al.
📚 Published In: Cephalalgia
📅 Publication Date: 2025 Dec
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.